RHYTHM

Serial Number 88976878
Registration 6035604
700

Registration Progress

Application Filed
May 8, 2019
Under Examination
Oct 1, 2019
Approved for Publication
Aug 6, 2019
Published for Opposition
Aug 6, 2019
Registered
Apr 14, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-04-14)
Due: Apr 14, 2026 271 days

Trademark Image

RHYTHM

Basic Information

Serial Number
88976878
Registration Number
6035604
Filing Date
May 8, 2019
Registration Date
April 14, 2020
Published for Opposition
August 6, 2019
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 14, 2020
Registration
Registered
Classes
042

Rights Holder

Rhythm Pharmaceuticals, Inc.

03
Address
222 Berkeley Street, Suite 1200
BOSTON, MA 02116

Ownership History

Rhythm Pharmaceuticals, Inc.

Original Applicant
03
Boston, MA

Rhythm Pharmaceuticals, Inc.

Owner at Publication
03
Boston, MA

Rhythm Pharmaceuticals, Inc.

Original Registrant
03
BOSTON, MA

Legal Representation

Attorney
Peter G. Byrne, Esq.

USPTO Deadlines

Next Deadline
271 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-04-14)
Due Date
April 14, 2026
Grace Period Ends
October 14, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

34 events
Date Code Type Description Documents
Apr 14, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jun 20, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 20, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 20, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 20, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jun 20, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 20, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 2, 2022 A7OK O AMENDMENT UNDER SECTION 7 - PROCESSED Loading...
Aug 2, 2022 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Feb 24, 2022 ES7R I TEAS SECTION 7 REQUEST RECEIVED Loading...
Feb 16, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 16, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Feb 16, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 16, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 14, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 11, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Mar 10, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 22, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Feb 21, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 21, 2020 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Feb 21, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 22, 2020 IUAF S USE AMENDMENT FILED Loading...
Jan 22, 2020 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Jan 22, 2020 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Jan 22, 2020 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 1, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 6, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 6, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 17, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 24, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 13, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
May 24, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
May 23, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 11, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and product development services in the fields of metabolic diseases and disorders, including obesity [, diabetes, metabolic syndrome and cachexia, and gastrointestinal diseases and disorders, including gastroparesis, post-operative ileus, chronic constipation, and inflammatory bowel disease ]
First Use Anywhere: May 1, 2019
First Use in Commerce: May 1, 2019

Additional Information

Color Claim
Color is not claimed as a feature of the mark.
Other
In the statement, line 5 "diabetes, metabolic syndrome and cachexia, and" is deleted; lines 6 and 7 is deleted.

Classification

International Classes
042